The SIRPA gene helps certain immune cells tell the difference between the body’s own cells and cells that should be cleared away. If it does not work properly, this cleanup system may become less well controlled, which can affect inflammation and how the body handles blood cells or transplanted tissue. This gene plays an important role in immune signaling and is closely studied in cancer research because some tumors use this pathway to reduce immune attack.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, which are the active parts of cells. Others mainly guide when certain processes take place, where they happen, and how strongly they are carried out. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. For a deeper look at this subject, you can find more in LearnHub.
Overview
SIRPAGene function
What if the gene works
The SIRPA gene helps make a surface protein on immune cells that recognizes a marker on healthy body cells. This signal helps limit unnecessary cell removal and keeps immune cleanup more controlled.
Risk
What if the gene does not work
SIRPA gene changes can range from milder to more severe and may weaken recognition of the CD47 “don’t eat me” signal. This can disrupt macrophage signaling and reduce control over engulfing other cells.
Treatment
What does that mean for your treatment
No SIRPA-specific treatment or drug choice is currently established for people with a pathogenic or loss-of-function variant in the SIRPA gene. Researchers are studying the CD47–SIRPA pathway in cancer, because blocking this signal may help immune cells recognize and clear tumor cells, but this has not led to care based on SIRPA variants.
Gene function
What if the gene works
Your immune system needs ways to avoid clearing healthy cells while still removing material that no longer belongs. The SIRPA gene helps provide that balance. It gives certain immune cells a surface protein that reads safety signals from the body’s own cells and adjusts immune activity in response.
The SIRPA gene makes a protein on immune cells that can bind to CD47, a marker found on many of your body’s own cells. This contact tells the immune cell that the nearby cell is part of you and should usually be left alone.
When the SIRPA protein receives that self signal, it sends a calming message inside the immune cell. This helps control phagocytosis (cell eating), so cleanup cells do not engulf healthy cells too readily.
Inside immune cells, SIRPA acts like a checkpoint that tones down activating signals after CD47 binding. This helps explain how the SIRPA gene works in the immune system to support steady, controlled surveillance.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help explain normal differences between people, such as appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can more substantially change how a gene works and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SIRPA gene can change the shape, stability, or amount of its protein on the cell surface, which may weaken binding to CD47 or alter signaling inside immune cells. In explaining how variants influence the SIRPA gene's function, milder changes may slightly reduce protein stability or signaling, while more severe variants can greatly lower cell surface expression or leave little to no working protein. The functional effect depends on the exact DNA change and where it occurs in the gene.
How variants are linked to conditions
The SIRPA gene does not yet have a broadly confirmed link to a specific health condition, though this can change as research develops. In research on how variants in the SIRPA gene are linked to conditions, no single widely accepted SIRPA related diagnosis has been established, so personal test results are best interpreted with a doctor or genetic counselor.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a usual part of human biology. Most do not directly affect health and simply contribute to natural variation among people. For many genes, having a variant associated with a condition points to a possible link rather than a clear diagnosis, particularly when several genes and environmental influences play a role. In other situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SIRPA gene. In most settings, changes in SIRPA are studied as one small part of a much bigger picture rather than a clear, stand-alone cause of disease. Anyone concerned about personal or family risk should speak with a doctor or genetic counselor.
Inheritance of SIRPA variants
There is not yet a broadly confirmed Mendelian inheritance pattern tied to a specific condition for the SIRPA gene, so how variants of the SIRPA gene are inherited in relation to disease is still being clarified. The SIRPA gene is located on chromosome 20, which is an autosome. That means you inherit one copy from your mother and one copy from your father.
What does my SIRPA result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific health condition for the SIRPA gene, though this can change as research grows. If you have a specific SIRPA result and questions about what it could mean for relatives, a doctor or genetic counselor can help explain it in the context of your family.
Genetic information
Genetic testing
How you find out about variants
Variants in the SIRPA gene are found through genetic testing, usually using blood, saliva, or a cheek swab. If you want to know how to test for SIRPA gene variants, a lab reads your DNA and compares it with a reference sequence to look for changes, then classifies them by their likely health effect.
When should I consider getting a genetic test?
There is not yet a broadly established medical reason to test the SIRPA gene on its own. Decisions about genetic testing are usually based on your personal health and family history and are best made with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic finding can provide valuable insight, but what it reveals depends on the condition and the type of variant involved. Over time, many factors such as lifestyle, environment, age, and medical history also shape how the body functions. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body absorbs, breaks down, transports, or responds to a drug, so the same treatment may work better for one person and less well for another. This is common and can influence how much benefit someone gets from a medication or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect their response to medications. It studies links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body handles it. This information can support more informed, more individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the SIRPA gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding routine medication choices, so general questions about medicines or side effects are best discussed with your doctor. SIRPA is being studied in cancer research linked to treatments that affect how immune cells recognize other cells, but this is not part of standard prescribing.
History
The SIRPA gene entered the scientific literature in the 1990s, when several research groups studying immune cell signaling identified the same gene under different names, including SHPS-1 and BIT. Initially understood only through visible traits, later recognized as tied to a specific gene, early work focused on how its protein appeared on the surface of immune cells. As medical science evolved, so did understanding of this gene. In the early 2000s, studies linking SIRPA to CD47 drew wider attention because this pathway became important in cancer immunology research. Over time, descriptions became more precise. Today, the history of the SIRPA gene reflects a broader shift from basic cell biology to research with potential clinical relevance.